Medicines List

The product has not yet been released on the market.

Description

Linagliptin/Metformin Tchaikapharma contains the active substances linagliptin and metformin and belongs to the group of medicines used for the treatment of type 2 diabetes mellitus. Linagliptin increases insulin secretion and reduces blood glucose levels, while metformin decreases glucose production in the body and improves insulin sensitivity. Their combined action helps to achieve effective blood glucose control.

Indications

Linagliptin/Metformin Tchaikapharma is indicated in adult patients with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control:

• in patients who have not achieved adequate glycemic control with the maximum tolerated dose of metformin administered as monotherapy;
• in combination with other medicinal products for the treatment of diabetes, including insulin, in patients who have not achieved adequate glycemic control with metformin and these medicinal products;
• in patients already treated with a combination of linagliptin and metformin administered as separate tablets.

Subject to medical prescription.

Concentration and pharmaceutical form: 2,5 mg /850 mg; 2,5 mg /1000 mg film-coated tablets

The product has not yet been released on the market.

Description

Endora contains the active substance edoxaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent blood clots from forming. It works by blocking the activity of factor Xa, which is an important component of blood clotting.

Indications

Endora is indicated in prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA).

Subject to medical prescription.

Concentration and pharmaceutical form: 30 mg, 60 mg tablets

Description

Diab PR prolonged-release tablets is a medicine that reduces blood sugar levels (oral anti-diabetic medicine belonging to the sulfonylurea group).

Indications

Diab PR is used in a certain form of diabetes (type 2 diabetes mellitus) in adults, when diet, exercise and weight loss alone do not have an adequate effect on keeping blood sugar at the correct level.

Subject to medical prescription.

Concentration and pharmaceutical form: 60 mg prolonged-release tablets

Description

Felixa contain the active substance febuxostat and belongs to the group of medicines known as antigout drugs.

Indications

Felixa is used to treat gout, which is associated with an excess of a chemical called uric acid (urate) in the body. In some people, the amount of uric acid builds up in the blood and may become too high to remain soluble. When this happens, urate crystals may form in and around the joints and kidneys. These crystals can cause sudden, severe pain, redness, warmth and swelling in a joint (known as a gout attack). Left untreated, larger deposits called tophi may form in and around joints. These tophi may cause joint and bone damage.

Felixa works by reducing uric acid levels. Keeping uric acid levels low by taking Felixa once every day stops crystals building up, and over time it reduces symptoms. Keeping uric acid levels sufficiently low for a long enough period can also shrink tophi.

Subject to medical prescription.

Concentration and pharmaceutical form: 80 mg; 120 mg film-coated tablets